EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Resistance of Platelets in Hypercholesterolemia to Inhibition by Activated Coagulation Factor X

Nighat Kahn, Bilal Khan, Asru K. Sinha

ISRN Vascular Medicine · 2011

DOI: 10.5402/2011/165018 ↗
AbstractBibliografische Angaben

Abstract

Platelet hyperactivity may be involved in the pathogenesis of both thrombogenesis and hypercholesterolemia. The cholesterol-enriched states may contribute to accelerated development of atherosclerosis. The effect of high cholesterol on platelet activation and on inhibition by coagulation factor Xa, was studied in vitro . Incubation of normal platelets ( n = 20 ) with cholesterol-rich dispersion resulted in a small increase of platelet aggregation (PA) and thromboxane A 2 ( TXA 2 ) synthesis when compared with platelets incubated with cholesterol-normal dispersion. In hypercholesterolemic patients ( n = 20 ), ADP-induced PA and TXA 2 synthesis showed only small increases over normal controls. Addition of factor Xa (1 unit/mL) prevented the ADP-induced PA and markedly inhibited TXA 2 synthesis in normal platelets ( 1.3 ± 0.2 and 8.7 ± 2.0 pmol TXA 2 / 10 8 platelets, with and without factor Xa, resp.). However, factor Xa failed to significantly suppress TXA 2 synthesis in cholesterol-incubated normal platelets ( 9.5 ± 1.4 and 11.8 ± 1.3 pmol TXA 2 / 10 8 platelets, with and without factor Xa; resp., P = NS ) as well as in platelets from patients with hypercholesterolemia ( 8.6 ± 4.0 and 10.9 ± 4.9 pmol TXA 2 / 10 8 platelets, with and without factor Xa; resp., P = NS ). Exposure of platelets to high cholesterol concentrations, in vitro and in vivo , marginally increased PA and TXA 2 synthesis but resulted in loss of responsiveness to factor Xa, which could significantly contribute to platelet activation in hypercholesterolemic states.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →